Miguel Hueso: Mechanical Valve Anticoagulation in a Dialysis Patient With Calciphylaxis
Miguel Hueso, Medical Specialist in Nephrology at Germans Trias i Pujol University Hospital, shared a post on LinkedIn about a recent article he and Aida Valverde-Farre co-authored, published in JACC Journals, adding:
” Vitamin K antagonists remain the standard of care for patients with mechanical heart valves.
However, their use can be particularly challenging and associated with serious complications in patients with complex comorbidities.
We’re happy to share the case of an elderly woman with a mechanical aortic valve who developed calciphylaxis and had a favorable outcome following a switch from acenocoumarol to apixaban.
We recently published the case in JACC and presented it at the SEC Congress.
Read the full case here.
We hope this case will contribute to the discussion on anticoagulation management in challenging clinical situations.”
Title: Apixaban in a Dialysis Patient With Valvular Heart Disease and Calciphylaxis: Rethinking Conventional Anticoagulation
Authors: Miguel Hueso, Aida Valverde-Farre
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 1, 2026, 14:23Shamee Shastry: New Handbook Highlights In-House Reagent Preparation for Transfusion Medicine
-
Nov 1, 2026, 14:11Cesar de Almeida Neto: REDS-IV Study on Donor Deferrals Wins Best Scientific Paper at HEMO 2026
-
Nov 1, 2026, 13:08Mark Gabot: Subcostal 4-Chamber View – PE with McConnell Sign
-
Nov 1, 2026, 12:58Alejandro González Veliz: More Mechanical Support Does Not Mean Better Survival
-
Nov 1, 2026, 12:49Asim Alam: Could Longer Shelf Life Reduce Platelet Waste?
-
Nov 1, 2026, 12:42Nicolas Hubacz: How Cells Make Room for Their DNA
-
Nov 1, 2026, 12:33Discover the Venue for EAHAD 2027
-
Nov 1, 2026, 12:25Sonia Wolf: GLP-1 Receptor Agonists in Sickle Cell Disease
-
Nov 1, 2026, 12:11Marine Sargsyan: Coronary Care Disparities Across the ESC EuroAsia Region